Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
J Psychopharmacol. 2022 Apr;36(4):460-469. doi: 10.1177/02698811211069096. Epub 2022 Feb 1.
Benzodiazepine treatment recommendations for older adults differ markedly between guidelines, especially their advice on the acceptability of long-term use.
Using population-based data we compared risks associated with chronic versus intermittent benzodiazepine usage in older adults. The primary outcome was falls resulting in hospital/emergency department visits.
We undertook a retrospective population-based cohort study using linked healthcare databases in adults aged ⩾ 66 years in Ontario, Canada, with a first prescription for benzodiazepines. Chronic and intermittent benzodiazepine users, based on the 180 days from index prescription, were matched (1:2 ratio) by sex, age and propensity score, then followed for up to 360 days. Hazard ratios (HRs) for outcomes were calculated from Cox regression models.
A total of 57,041 chronic and 113,839 matched intermittent users were included. Hospitalization/emergency department visits for falls occurred during follow up in 4.6% chronic versus 3.2% intermittent users (HR = 1.13, 95% confidence interval (CI): 1.08 to 1.19; < 0.0001). There were significant excess risks in chronic users for most secondary outcomes: hip fractures, hospitalizations/emergency department visits, long-term care admission and death, but not wrist fractures. Adjustment for benzodiazepine dosage had minimal impact on HRs.
Our study demonstrates evidence of significant excess risks associated with chronic benzodiazepine use compared to intermittent use. The excess risks may inform decision-making by older adults and clinicians about whether short- or long-term benzodiazepine use is a reasonable option for symptom management.
老年人群中苯二氮䓬类药物治疗建议在指南之间存在显著差异,尤其是关于长期使用的可接受性的建议。
我们使用基于人群的数据比较了老年人群中长期和间歇性使用苯二氮䓬类药物与相关风险,主要结局为因跌倒导致的住院/急诊就诊。
我们开展了一项基于人群的回顾性队列研究,使用加拿大安大略省≥66 岁人群的医疗保健数据库,这些患者均有首次苯二氮䓬类药物处方。根据索引处方后的 180 天,将慢性和间歇性苯二氮䓬类药物使用者(1:2 比例)按照性别、年龄和倾向评分进行匹配,然后随访 360 天。使用 Cox 回归模型计算结局的风险比(HR)。
共纳入 57041 名慢性使用者和 113839 名匹配的间歇性使用者。在随访期间,慢性使用者中有 4.6%发生跌倒相关的住院/急诊就诊,而间歇性使用者为 3.2%(HR=1.13,95%置信区间:1.08 至 1.19; < 0.0001)。慢性使用者发生大多数次要结局(髋部骨折、住院/急诊就诊、长期护理入院和死亡)的风险显著增加,但腕部骨折除外。调整苯二氮䓬类药物剂量对 HR 影响较小。
我们的研究表明,与间歇性使用相比,长期使用苯二氮䓬类药物与显著的额外风险相关。这些额外的风险可能为老年患者和临床医生在考虑短期或长期使用苯二氮䓬类药物来控制症状时提供决策依据。